GB2131292B - Progestational pharmaceutical formulations - Google Patents

Progestational pharmaceutical formulations

Info

Publication number
GB2131292B
GB2131292B GB08234226A GB8234226A GB2131292B GB 2131292 B GB2131292 B GB 2131292B GB 08234226 A GB08234226 A GB 08234226A GB 8234226 A GB8234226 A GB 8234226A GB 2131292 B GB2131292 B GB 2131292B
Authority
GB
United Kingdom
Prior art keywords
progestational
pharmaceutical formulations
formulations
pharmaceutical
progestational pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08234226A
Other versions
GB2131292A (en
Inventor
Dr Christopher H Mortimer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB08234226A priority Critical patent/GB2131292B/en
Publication of GB2131292A publication Critical patent/GB2131292A/en
Application granted granted Critical
Publication of GB2131292B publication Critical patent/GB2131292B/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB08234226A 1982-12-01 1982-12-01 Progestational pharmaceutical formulations Expired GB2131292B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB08234226A GB2131292B (en) 1982-12-01 1982-12-01 Progestational pharmaceutical formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08234226A GB2131292B (en) 1982-12-01 1982-12-01 Progestational pharmaceutical formulations

Publications (2)

Publication Number Publication Date
GB2131292A GB2131292A (en) 1984-06-20
GB2131292B true GB2131292B (en) 1987-03-11

Family

ID=10534652

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08234226A Expired GB2131292B (en) 1982-12-01 1982-12-01 Progestational pharmaceutical formulations

Country Status (1)

Country Link
GB (1) GB2131292B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3738620A1 (en) * 1987-11-13 1989-05-24 Luderschmidt Christoph USE OF ETHISTERONE FOR TOPICAL TREATMENT OF ACNE OR ANDROGENETIC ALOPECIA
US6190693B1 (en) * 1998-04-17 2001-02-20 Ortho-Mcneil Pharamceutical, Inc. Pharmaceutical methods of delivering folic acid
HUP9900213A1 (en) * 1999-02-01 2000-12-28 Gábor Bogye Pharmaceutical compositions for diminishing side-effects of gestagene-type hormone-containing compositions

Also Published As

Publication number Publication date
GB2131292A (en) 1984-06-20

Similar Documents

Publication Publication Date Title
DE3378523D1 (en) Pharmaceutical formulations
GB8326565D0 (en) Pharmaceutical compositions
HK16090A (en) Pharmaceutical compositions
ZA833781B (en) Pharmaceutical compositions
EP0093551A3 (en) Pharmaceutical composition
SG21388G (en) Pharmaceutical formulations
GB2118176B (en) Pharmaceutical compositions
GB2117766B (en) Pharmaceutical compositions
PT77323A (en) Pharmaceutical compositions
GB8429749D0 (en) Pharmaceutical compositions
GB8313814D0 (en) Pharmaceutical compositions
DE3377696D1 (en) Pharmaceutical compositions
GB8328896D0 (en) Pharmaceutical composition
US4594359B1 (en) Pharmaceutical compositions
GB2114001B (en) Nasel pharmaceutical compositions
GB2131292B (en) Progestational pharmaceutical formulations
GB8305028D0 (en) Pharmaceutical compositions
GB8330810D0 (en) Pharmaceutical compositions
GB8314736D0 (en) Pharmaceutical compositions
ZA833692B (en) Pharmaceutical formulations
GB8331068D0 (en) Pharmaceutical compositions
GB8329391D0 (en) Pharmaceutical compositions
GB8314540D0 (en) Pharmaceutical composition
IE822854L (en) Pharmaceutical formulation
DE3372706D1 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee